Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$533M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Micron Technology
MU
|
+$272M |
| 4 |
Eli Lilly
LLY
|
+$232M |
| 5 |
Super Micro Computer
SMCI
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
NVIDIA
NVDA
|
+$413M |
| 3 |
Tesla
TSLA
|
+$403M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Johnson & Johnson
JNJ
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Industrials | 9.63% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Assembly Biosciences
ASMB
$524M
| $994K | ﹤0.01% |
65,624
+10,713
| +20% | +$163K |
|
|
TSE
2452
DELISTED
Trinseo
TSE
| $992K | ﹤0.01% |
194,100
+65,400
| +51% | +$218K |
|
2453
Simulations Plus
SLP
$371M
| $989K | ﹤0.01% |
+30,900
| New | +$1.14M |
|
2454
Karat Packaging
KRT
$846M
| $987K | ﹤0.01% |
38,115
+4,600
| +14% | +$123K |
|
2455
Eltek
ELTK
$59.5M
| $982K | ﹤0.01% |
90,023
-700
| -0.8% | -$7.23K |
|
2456
Bowman Consulting
BWMN
$472M
| $980K | ﹤0.01% |
40,700
+26,879
| +194% | +$744K |
|
|
KRON
2457
DELISTED
Kronos Bio
KRON
| $979K | ﹤0.01% |
979,054
+214,928
| +28% | +$238K |
|
2458
KVH Industries
KVHI
$162M
| $975K | ﹤0.01% |
201,913
+24,513
| +14% | +$112K |
|
2459
Protalix BioTherapeutics
PLX
$197M
| $975K | ﹤0.01% |
955,900
+151,300
| +19% | +$159K |
|
2460
Passage Bio
PASG
$14.1M
| $975K | ﹤0.01% |
69,642
+13,363
| +24% | +$213K |
|
2461
Columbus McKinnon
CMCO
$599M
| $975K | ﹤0.01% |
27,076
-80,809
| -75% | -$2.74M |
|
2462
Oportun Financial
OPRT
$370M
| $974K | ﹤0.01% |
346,693
+119,693
| +53% | +$348K |
|
2463
Vanguard Morningstar Large-Cap ETF
VV
$54B
| $974K | ﹤0.01% |
3,700
-2,900
| -44% | -$736K |
|
2464
Cerus
CERS
$468M
| $972K | ﹤0.01% |
558,500
+349,000
| +167% | +$733K |
|
2465
Sociedad Química y Minera de Chile
SQM
$20.7B
| $971K | ﹤0.01% |
+23,300
| New | +$892K |
|
2466
iShares MSCI Indonesia ETF
EIDO
$489M
| $970K | ﹤0.01% |
43,100
+1,079
| +3% | +$22.9K |
|
2467
Outdoor Holding Co
POWW
$251M
| $970K | ﹤0.01% |
678,000
+88,600
| +15% | +$140K |
|
2468
Weyco Group
WEYS
$419M
| $968K | ﹤0.01% |
28,426
+700
| +3% | +$22.8K |
|
2469
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14B
| $960K | ﹤0.01% |
13,700
-8,100
| -37% | -$547K |
|
2470
Marcus Corp
MCS
$944M
| $960K | ﹤0.01% |
63,689
-176,211
| -73% | -$2.32M |
|
2471
Neurogene
NGNE
$710M
| $957K | ﹤0.01% |
22,807
-30,000
| -57% | -$1.16M |
|
|
EGRX
2472
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $956K | ﹤0.01% |
256,350
+12,100
| +5% | +$57.7K |
|
|
VBNK
2473
VersaBank
VBNK
$615M
| $956K | ﹤0.01% |
71,970
+43,570
| +153% | +$529K |
|
|
FLG
2474
Flagstar Bank National Association
FLG
$5.9B
| $955K | ﹤0.01% |
85,028
-1,287,234
| -94% | -$13.7M |
|
2475
Riverview Bancorp
RVSB
$110M
| $952K | ﹤0.01% |
202,119
-1,539
| -0.8% | -$6.85K |
|
Similar funds
Renaissance Technologies's Q3 2024 Portfolio in Review
As of Q3 2024, Renaissance Technologies held 4,024 positions worth $66.5B, up 13% from $59B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $3.2B of net new capital in Q3 2024, opening 578 new positions and adding to 1,558 existing holdings. Its largest new stake was Micron Technology: 2,604,914 shares worth $270M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $413M trimmed.
- Renaissance Technologies's largest Q3 2024 buy was Micron Technology: 2,604,914 shares worth $270M.
- Renaissance Technologies added most to Microsoft in Q3 2024, an estimated $533M increase.
- Renaissance Technologies's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $413M.
- Renaissance Technologies fully exited Broadcom in Q3 2024, selling an estimated $472M.
- Renaissance Technologies's ten largest holdings make up 11% of its $66.5B portfolio in Q3 2024.
- Renaissance Technologies opened 578 new positions and closed 539 in Q3 2024.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $66.5B.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.